Ropes & Gray won Pharma and Health Care Corporate Practice of the Year honors at The American Lawyer 2024 Industry Awards. The firm previously received the award in 2022. The award recognizes a firm that is leading impactful and innovative legal work in healthcare and pharmaceuticals.
Ropes & Gray has advised on transformative deals in the healthcare and life sciences sectors and in 2022 and 2023 guided 1Life Healthcare, Inc. (One Medical) in its $3.9 billion sale to Amazon, Signify Health in its $8 billion sale to CVS, Pfizer in its $11.6 billion acquisition of Biohaven Pharmaceuticals and Immunogen in its $10.1 billion sale to AbbVie. Additionally, the firm is being recognized for facilitating over 110 complex licensing and collaboration deals, with a total value of $55 billion, including several top biopharmaceutical licensing deals in 2023.
The firm advises clients on the full spectrum of complex healthcare and life sciences matters across transactions, licensing, regulatory, litigation, investigations and enforcement. Read more about the firm’s healthcare and life sciences industry group.
The 2024 Industry Award honorees were recognized at The American Lawyer's annual gala on November 13 in New York City. Learn more about the award winners.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.